Ma Xiong, male, doctor of medicine, doctoral supervisor, researcher, chief physician and associate professor. He is good at the diagnosis and treatment of chronic hepatobiliary diseases, especially autoimmune liver disease and fatty liver. He is currently the deputy director of the Department of Gastroenterology, Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, the deputy director of Shanghai Institute of Digestive Diseases, the deputy director of Shanghai Fatty Liver Disease Diagnosis and Treatment Research Center, the deputy director of the Youth Committee of the Digestive Branch of the Chinese Medical Association, the member of the Hepatobiliary Collaboration Group of the Digestive Branch of the Chinese Medical Association, the international member of American AASLD, the member of Shanghai Hepatology Association, the leader of the autoimmune liver disease group of Shanghai Hepatology Association, the member of the drug-induced liver disease branch of Shanghai Hepatology Association, and the deputy director of the Youth Committee of Shanghai Medical Association. He has published more than 50 papers in domestic and foreign magazines such as Hepatology and Journal of Hepatology, and SCI has included 16 papers. * * * Co-edited 5 monographs: Fundamentals and Clinics of Autoimmune Liver Diseases, Refractory Digestive System Diseases, Characteristic Diagnosis and Treatment Techniques of Digestive System Diseases, Cholecystitis and Gallstones and Concise Chinese-English Gastroenterology; Deputy Editor 1: Department of Basic and Clinical Gastroenterology, with 3 assistant editors. At present, he is a member of the Editorial Board of Digestive Diseases, International Journal of Gastroenterology (formerly Foreign Medical Digestion Volume), and the Theory and Practice of Gastroenterology, Liver and Internal Medicine. As the first person in charge, he undertook four general projects of the National Natural Fund, the key basic project of Shanghai Science and Technology Commission 1, and the "Pujiang Talent Plan" of Shanghai 1, and led the innovative research team of non-viral liver disease immunology of Shanghai Education Commission.